VITRO AND IN VIVO CHARACTERIZATION OF EYP001 A NOVEL, POTENT AND SELECTIVE FXR AGONIST NOW IN A PHASE 2 CLINICAL TRIAL IN NASH

被引：0
|
作者：
Radreau, Pauline [1 ]
Joly, Stephane [1 ]
Dubos, Claire [1 ]
Vonderscher, Jacky [1 ]
Scalfaro, Pietro [1 ]
Meldrum, Eric [1 ]
Darteil, Raphael [1 ]
机构：
[1] Enyo Pharma SA, Lyon, France
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2140
引用
收藏
页码：1267A / 1267A
页数：1
相关论文
共 50 条
  • [21] Characterization of Eltenac and novel COX-2 selective thiopheneacetic acid analogues in vitro and in vivo
    Klein, Thomas
    Dullweber, Frank
    Brehm, Christoph
    Prinz, Walter
    Baudler, Monika
    Figala, Volker
    Hermann, Michael
    BIOCHEMICAL PHARMACOLOGY, 2008, 76 (06) : 717 - 725
  • [22] Characterization of a Novel, Potent and Selective Small Molecule Spleen Tyrosine Kinase (SYK) Inhibitor in In Vitro and In Vivo Models of Asthma.
    Crackower, M. A.
    Moy, L. Y.
    Jia, Y.
    Yu, H.
    Vincent, S.
    Miller, J. R.
    Lieber, G.
    Fernandez, X.
    Caniga, M.
    Gil, M.
    Wilhelm, A.
    Houshyar, H.
    Northrup, A.
    Chapman, R.
    Abraham, W. M.
    Kelly, N.
    Hickey, E.
    Miller, T.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB49 - AB49
  • [23] AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation
    Feuerbach, Dominik
    Pezous, Nicole
    Weiss, Markus
    Shakeri-Nejad, Kasra
    Lingenhoehl, Kurt
    Hoyer, Daniel
    Hurth, Konstanze
    Bilbe, Graeme
    Pryce, Christopher R.
    McAllister, Kevin
    Chaperon, Frederique
    Kucher, Klaus
    Johns, Donald
    Blaettler, Thomas
    Lopez Lopez, Cristina
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (05) : 1292 - 1304
  • [24] In vitro and in vivo characterization of an orally-active Cannabinoid receptor 2 (CB2)-selective agonist, M68400
    Masubuchi, Kazuhiro
    Kato, Yutaka
    Sogawa, Yoshitaka
    Okano, Akihiro
    Yumiya, Yasunobu
    Naba, Hiroyasu
    Muramatsu, Hiroyuki
    Nishiyama, Yuuichi
    Haruyama, Toshio
    Yamasaki, Fumiaki
    Furusako, Shoji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 247P - 247P
  • [25] In vitro and in vivo characterization of PF-04418948, a novel, potent and selective prostaglandin EP2 receptor antagonist (vol 164, pg 1847, 2011)
    Forselles, K. J.
    Root, J.
    Clarke, T.
    Davey, D.
    Aughton, K.
    Dack, K.
    BRITISH JOURNAL OF PHARMACOLOGY, 2012, 166 (03) : 1192 - 1192
  • [26] In vitro and in vivo activity of R547:: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials
    DePinto, Wanda
    Chu, Xin-Jie
    Yin, Xuefeng
    Smith, Melissa
    Packman, Kathryn
    Goelzer, Petra
    Lovey, Allen
    Chen, Yingsi
    Qian, Hong
    Hamid, Rachid
    Xiang, Qing
    Tovar, Christian
    Blain, Roger
    Nevins, Tom
    Higgins, Brian
    Luistro, Leopoldo
    Kolinsky, Kenneth
    Felix, Bernardo
    Hussain, Sazzad
    Heimbrook, David
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (11) : 2644 - 2658
  • [27] The First In Vitro and In Vivo Assessment Of Anfibatide, a Novel Glycoprotein Ib Antagonist, In Mice and In a Phase I Human Clinical Trial
    Hou, Yan
    Lei, Xi
    Li, Benjamin Xiaoyi
    Dai, Xiangrong
    Yang, Zhongqiang
    Qian, Fang
    Zhang, Guohui
    Xu, Zhengyu
    Liu, Jing
    Liang, Chaofan
    Zhao, Yanan
    Shen, Jie
    Zhou, Hui
    Wang, Yiming
    Marshall, Alexandra H.
    Ni, Heyu
    BLOOD, 2013, 122 (21)
  • [28] In vitro and in vivo pharmacological characterization of two novel selective cannabinoid CB2 receptor inverse agonists
    Cascio, Maria Grazia
    Bolognini, Daniele
    Pertwee, Roger G.
    Palazzo, Enza
    Corelli, Federico
    Pasquini, Serena
    Di Marzo, Vincenzo
    Maione, Sabatino
    PHARMACOLOGICAL RESEARCH, 2010, 61 (04) : 349 - 354
  • [29] A novel prostaglandin E2 receptor EP4-selective agonist attenuates inflammatory activation of macrophages in vitro and in vivo
    Takayama, Kiyoshi
    Asano, Yasuo
    Ueki, Mayumi
    Takahashi, Akiko
    Toda, Yoshihisa
    Seki, Takayuki
    Takahashi, Teisuke
    Onishi, Michihito
    Ono, Naoya
    Yagi, Makoto
    Ichikawa, Astushi
    CIRCULATION, 2006, 114 (18) : 258 - 258
  • [30] In vitro and in vivo characterization of KHK2455, a highly potent and selective indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor with a novel mechanism of action
    Mie, Motoya
    Kunieda, Kana
    Koshiba, Shoko
    Murakami, Takashi
    Horita, Shinya
    Fukuda, Yuichi
    Ishii, Toshihiko
    Nakai, Ryuichiro
    Nakamura, Kazuyasu
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
12345